ES2184735T3 - Peptidos y secuencias de acido nucleico asociados con el virus epstein barr. - Google Patents
Peptidos y secuencias de acido nucleico asociados con el virus epstein barr.Info
- Publication number
- ES2184735T3 ES2184735T3 ES93200691T ES93200691T ES2184735T3 ES 2184735 T3 ES2184735 T3 ES 2184735T3 ES 93200691 T ES93200691 T ES 93200691T ES 93200691 T ES93200691 T ES 93200691T ES 2184735 T3 ES2184735 T3 ES 2184735T3
- Authority
- ES
- Spain
- Prior art keywords
- peptides
- nucleic acid
- ebv
- antibodies
- barr virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
LA INVENCION DESCRIBE UNOS PEPTIDOS INMUNOQUIMICAMENTE REACTIVOS CON ANTICUERPOS PAR EL VIRUS EPSTEIN-BARR (EBV), QUE COMPRENDEN AL MENOS UNA PARTE DE LA PROTEINA VCA-P18 O VCA-P40, ENCODIFICADA DENTRO DE LOS MARCOS EBV DE LECTURA ABIERTA BFRF3 Y BDRF1 RESPECTIVAMENTE, O UNA DE SUS VARIANTES FUNCIONALES. TAMBIEN SE DESCRIBEN UNAS SECUENCIAS DE ACIDO NUCLEICO QUE ENCODIFICAN ESTOS PEPTIDOS,ANTICUERPOS MONOCLONALES CONTRA LOS MISMOS,LINEAS CELULARES CAPACES DE PRODUCIR ANTICUERPOS MONOCLONALES Y ANTICUERPOS ANTI-IDEOTIPO, ASI COMO LAS MOLECULAS DE VECTOR RECOMBINANTE QUE COMPRENDEN UNA SECUENCIA DE ACIDO NUCLEICO DE ACUERDO CON LA INVENCION Y LAS CELULAS HUESPED TRANSFORMADAS O TRANSFERIDAS CON ESAS MOLECULAS.POR ULTIMO SE DESCRIBEN LOS REAGENTES INMUNOLOGICOS Y LOS METODOS PARA DETECTAR LOS ANTICUERPOS EBV Y ANTI-EBV, Y UN METODO PARA AMPLIFICAR Y DETECTAR EL ACIDO NUCLEICO VIRICO EB.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92200721 | 1992-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2184735T3 true ES2184735T3 (es) | 2003-04-16 |
Family
ID=8210477
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93200691T Expired - Lifetime ES2184735T3 (es) | 1992-03-13 | 1993-03-10 | Peptidos y secuencias de acido nucleico asociados con el virus epstein barr. |
ES02075193T Expired - Lifetime ES2298325T3 (es) | 1992-03-13 | 1993-03-10 | Peptidos y secuencias de acido nucleico relacionadas con el virus epstein barr. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES02075193T Expired - Lifetime ES2298325T3 (es) | 1992-03-13 | 1993-03-10 | Peptidos y secuencias de acido nucleico relacionadas con el virus epstein barr. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5424398A (es) |
EP (2) | EP1225226B1 (es) |
JP (3) | JP4135996B2 (es) |
KR (1) | KR100291247B1 (es) |
AT (2) | ATE222291T1 (es) |
AU (1) | AU666920B2 (es) |
CA (1) | CA2092680C (es) |
DE (2) | DE69334191T2 (es) |
DK (2) | DK1225226T3 (es) |
ES (2) | ES2184735T3 (es) |
FI (1) | FI114802B (es) |
PT (1) | PT574048E (es) |
ZA (1) | ZA931797B (es) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0726315B1 (en) * | 1993-07-23 | 2001-10-17 | Hans Prof. Dr. Wolf | Epstein-Barr virus DNA sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
EP0649904B1 (en) * | 1993-09-14 | 2003-01-22 | bioMérieux BV | Diagnostic reagents for the detection of antibodies to EBV |
US5834747A (en) * | 1994-11-04 | 1998-11-10 | Pixel Instruments | Universal credit card apparatus and method |
DE19526384C2 (de) * | 1995-07-19 | 1997-07-10 | Biotest Ag | Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, sowie diese enthaltende Testkits zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern |
US5813500A (en) * | 1996-03-25 | 1998-09-29 | Tenneco Automotive Inc. | Anti-swish mechanism for a damper |
FR2765688B1 (fr) | 1997-07-04 | 1999-09-10 | Pasteur Institut | Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications |
US7105496B2 (en) | 1998-07-23 | 2006-09-12 | Northwestern University | Methods and compositions for inhibiting angiogenesis |
US6797691B1 (en) * | 1997-07-23 | 2004-09-28 | Northwestern University | Methods and compositions for inhibiting angiogenesis |
EP1627886A1 (en) * | 1997-10-07 | 2006-02-22 | Ono Pharmaceutical Co., Ltd. | Polypeptide, cDNA encoding the same, and use of them |
DE69940770D1 (de) * | 1998-03-04 | 2009-06-04 | Biomerieux Bv | Vervielfältigung und nachweis von ebv barf1 zur diagnose von nasopharyngealen karzinom |
US20030064917A1 (en) * | 1998-07-23 | 2003-04-03 | Crawford Susan E. | Methods and compositions for inhibiting angiogenesis |
US6159950A (en) * | 1998-10-16 | 2000-12-12 | Cornell Research Foundation, Inc. | Method of modulating hair growth |
JP4981229B2 (ja) * | 2000-02-25 | 2012-07-18 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | ハイブリッド血管内皮成長因子DNAsおよびタンパク質に関与する物質および方法 |
WO2003033520A2 (en) * | 2001-09-24 | 2003-04-24 | University Of Pittburgh Of The Commonwealth System Of Higher Education | Anticancer vaccine and diganostic methods and reagents |
US7138370B2 (en) | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
US7521053B2 (en) | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
JP2005530716A (ja) * | 2002-03-27 | 2005-10-13 | アメリカ合衆国 | ヒトにおける癌の治療方法 |
US7507568B2 (en) * | 2002-09-25 | 2009-03-24 | The Proctor & Gamble Company | Three dimensional coordinates of HPTPbeta |
US7226755B1 (en) * | 2002-09-25 | 2007-06-05 | The Procter & Gamble Company | HPTPbeta as a target in treatment of angiogenesis mediated disorders |
US6886670B2 (en) * | 2003-09-29 | 2005-05-03 | Tenneco Automotive Operating Company Inc. | Extra support land for valve disc |
DE10307517A1 (de) * | 2003-02-21 | 2004-09-02 | Mikrogen Molekularbiologische Entwicklungs-Gmbh | Von Kapsidantigenen des Epstein-Barr-Virus abgeleitete Peptide und ihre Verwendung |
US6899207B2 (en) | 2003-09-29 | 2005-05-31 | Tenneco Automotive Operating Company Inc. | Extra support area for valve disc |
EP1781826A4 (en) * | 2004-06-12 | 2009-04-29 | Univ Oregon Health & Science | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ORTHOPOXVIRUS |
US7278987B2 (en) * | 2004-07-09 | 2007-10-09 | Anthony Solazzo | Ergonomic urological catheterization/irrigation tray |
WO2007044033A2 (en) | 2004-12-07 | 2007-04-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen |
WO2007064844A2 (en) | 2005-12-01 | 2007-06-07 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Anti-viral griffithsin compounds, compositions, and methods of use |
MX2008008233A (es) | 2005-12-23 | 2009-03-27 | Univ Lausanne | Peptidos sinteticos para utilizarse como inhibidores de secrecion de neurotransmisores y como inductores de relajacion muscular. |
US7868228B2 (en) | 2006-01-31 | 2011-01-11 | Monsanto Technology Llc | Phosphopantetheinyl transferases from bacteria |
US7973142B2 (en) | 2006-04-07 | 2011-07-05 | Warner Chilcott Company | Antibodies that bind human protein tyrosine phosphatase beta (HPTPβ) |
US7795444B2 (en) * | 2006-06-27 | 2010-09-14 | Warner Chilcott Company | Human protein tyrosine phosphatase inhibitors and methods of use |
US7589212B2 (en) * | 2006-06-27 | 2009-09-15 | Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
US8846685B2 (en) | 2006-06-27 | 2014-09-30 | Aerpio Therapeutics Inc. | Human protein tyrosine phosphatase inhibitors and methods of use |
US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
EP2671891A3 (en) | 2008-06-27 | 2014-03-05 | Amgen Inc. | Ang-2 inhibition to treat multiple sclerosis |
WO2010011994A2 (en) | 2008-07-25 | 2010-01-28 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Polypeptides and uses thereof |
DK2337791T3 (da) | 2008-10-14 | 2013-11-04 | Monsanto Technology Llc | Anvendelse af fedtsyredesaturaser fra Hemiselmis SPP |
US9096555B2 (en) | 2009-01-12 | 2015-08-04 | Aerpio Therapeutics, Inc. | Methods for treating vascular leak syndrome |
US8883832B2 (en) | 2009-07-06 | 2014-11-11 | Aerpio Therapeutics Inc. | Compounds, compositions, and methods for preventing metastasis of cancer cells |
PL2451279T3 (pl) | 2009-07-06 | 2019-09-30 | Aerpio Therapeutics, Inc. | Pochodne benzosulfonamidowe, ich kompozycje i ich zastosowanie w zapobieganiu przerzutom komórek nowotworowych |
WO2012009705A1 (en) | 2010-07-15 | 2012-01-19 | Zyngenia, Inc. | Ang-2 binding complexes and uses thereof |
EP2673297A2 (en) | 2011-02-11 | 2013-12-18 | Zyngenia, Inc. | Monovalent and multivalent multispecific complexes and uses thereof |
WO2012162561A2 (en) | 2011-05-24 | 2012-11-29 | Zyngenia, Inc. | Multivalent and monovalent multispecific complexes and their uses |
US9605083B2 (en) | 2011-08-16 | 2017-03-28 | Emory University | JAML specific binding agents, antibodies, and uses related thereto |
CN105451767B (zh) | 2013-03-15 | 2019-10-18 | 泽恩格尼亚股份有限公司 | 多价和单价多特异性复合物及其用途 |
EP2813849A1 (en) * | 2013-06-10 | 2014-12-17 | Charité-Universitätsmedizin Berlin (Charité) | EBV-specific immune signature as diagnostic markers in Chronic Fatigue Syndrome (CFS) |
US11034736B2 (en) | 2014-01-09 | 2021-06-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-viral cnidarins |
WO2016130628A1 (en) | 2015-02-10 | 2016-08-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Griffithsin mutants |
EP3256144B1 (en) | 2015-02-13 | 2021-03-24 | The Board of Trustees of the University of Illionis | Peptide inhibition of ccr3-mediated diseases or conditions |
CA2987437C (en) | 2015-06-15 | 2024-04-09 | Monash University | Il-37 variants |
JP2018533578A (ja) | 2015-10-30 | 2018-11-15 | モナシュ ユニバーシティー | グルコース代謝改善のための方法及び組成物 |
CN108490177B (zh) * | 2018-02-08 | 2020-12-29 | 深圳市新产业生物医学工程股份有限公司 | 鼻咽癌抗体检测试剂、其制备方法及鼻咽癌检测试剂盒 |
EP4003393A1 (en) | 2019-07-29 | 2022-06-01 | The Board Of Trustees Of The University Of Illinois | Composition and method for promoting wound healing |
WO2021123173A1 (en) | 2019-12-20 | 2021-06-24 | F. Hoffmann-La Roche Ag | Il-37 fusion proteins and uses thereof |
WO2022109053A1 (en) | 2020-11-18 | 2022-05-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Tyrosyl-lock peptides |
WO2023192802A1 (en) | 2022-04-01 | 2023-10-05 | The Board Of Trustees Of The University Of Illinois | Notch1 and notch4 decoys and methods of use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3479289D1 (en) * | 1983-11-07 | 1989-09-14 | Wistar Inst | Immune response to tumours and viruses induced by anti-idiotype antibodies |
US4699880A (en) * | 1984-09-25 | 1987-10-13 | Immunomedics, Inc. | Method of producing monoclonal anti-idiotype antibody |
IE873041L (en) * | 1987-11-11 | 1989-05-11 | Ailbe Brennan | Viral antigens, diagnostic assay therefor and vaccines¹containing them |
WO1991002091A1 (en) * | 1989-08-10 | 1991-02-21 | Northwestern University | Method of identifying herpesviruses and oligonucleotides for use therein |
EP0585216A1 (en) * | 1989-11-24 | 1994-03-09 | The Council Of The Queensland Institue Of Medical Research | Im peptides |
ES2064082T3 (es) * | 1989-12-20 | 1995-01-16 | Schering Corp | Proteinas bcrf1 como inhibidores de interferon-gamma. |
JPH04310861A (ja) * | 1991-04-09 | 1992-11-02 | Kazuo Yanagi | 抗ebna抗体の測定方法および抗ebna抗体測定キット |
-
1993
- 1993-03-10 DE DE69334191T patent/DE69334191T2/de not_active Expired - Lifetime
- 1993-03-10 AT AT93200691T patent/ATE222291T1/de not_active IP Right Cessation
- 1993-03-10 PT PT93200691T patent/PT574048E/pt unknown
- 1993-03-10 AT AT02075193T patent/ATE380243T1/de not_active IP Right Cessation
- 1993-03-10 EP EP02075193A patent/EP1225226B1/en not_active Expired - Lifetime
- 1993-03-10 DK DK02075193T patent/DK1225226T3/da active
- 1993-03-10 DE DE69332197T patent/DE69332197T2/de not_active Expired - Lifetime
- 1993-03-10 EP EP93200691A patent/EP0574048B1/en not_active Expired - Lifetime
- 1993-03-10 ES ES93200691T patent/ES2184735T3/es not_active Expired - Lifetime
- 1993-03-10 DK DK93200691T patent/DK0574048T3/da active
- 1993-03-10 ES ES02075193T patent/ES2298325T3/es not_active Expired - Lifetime
- 1993-03-12 US US08/031,148 patent/US5424398A/en not_active Expired - Lifetime
- 1993-03-12 AU AU35152/93A patent/AU666920B2/en not_active Expired
- 1993-03-12 CA CA002092680A patent/CA2092680C/en not_active Expired - Lifetime
- 1993-03-12 ZA ZA931797A patent/ZA931797B/xx unknown
- 1993-03-12 FI FI931109A patent/FI114802B/fi not_active IP Right Cessation
- 1993-03-13 KR KR1019930003940A patent/KR100291247B1/ko not_active IP Right Cessation
- 1993-03-15 JP JP08009993A patent/JP4135996B2/ja not_active Expired - Lifetime
-
2004
- 2004-03-31 JP JP2004102197A patent/JP4106041B2/ja not_active Expired - Lifetime
-
2008
- 2008-03-31 JP JP2008089543A patent/JP4365440B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP4106041B2 (ja) | 2008-06-25 |
AU3515293A (en) | 1993-09-16 |
DK0574048T3 (da) | 2002-12-16 |
JP2008261851A (ja) | 2008-10-30 |
FI931109A (fi) | 1993-09-14 |
ATE222291T1 (de) | 2002-08-15 |
EP0574048A2 (en) | 1993-12-15 |
ATE380243T1 (de) | 2007-12-15 |
PT574048E (pt) | 2002-12-31 |
DE69332197D1 (de) | 2002-09-19 |
JP4365440B2 (ja) | 2009-11-18 |
AU666920B2 (en) | 1996-02-29 |
DE69332197T2 (de) | 2003-04-17 |
ZA931797B (en) | 1993-09-30 |
EP1225226A1 (en) | 2002-07-24 |
KR930019829A (ko) | 1993-10-19 |
ES2298325T3 (es) | 2008-05-16 |
CA2092680C (en) | 2006-08-08 |
US5424398A (en) | 1995-06-13 |
KR100291247B1 (ko) | 2001-06-01 |
FI931109A0 (fi) | 1993-03-12 |
DE69334191T2 (de) | 2008-11-27 |
FI114802B (fi) | 2004-12-31 |
DK1225226T3 (da) | 2008-04-14 |
JPH0690787A (ja) | 1994-04-05 |
JP2004261183A (ja) | 2004-09-24 |
JP4135996B2 (ja) | 2008-08-20 |
EP0574048A3 (es) | 1994-03-02 |
EP0574048B1 (en) | 2002-08-14 |
CA2092680A1 (en) | 1993-09-14 |
EP1225226B1 (en) | 2007-12-05 |
DE69334191D1 (de) | 2008-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2184735T3 (es) | Peptidos y secuencias de acido nucleico asociados con el virus epstein barr. | |
CA2143491A1 (en) | A novel peptide related to human programmed cell death and dna encoding it | |
UA50829C2 (uk) | Очищений поліпептид, що містить антиген вірусу гепатиту с, полінуклеотид, вектор, клітини, система експресії, моноклональне антитіло, препарат поліклональних антитіл, нуклеотидна проба, аналітичні набори, спосіб виявлення нуклеїнових кислот, способи імуноаналізу, вакцина, спосіб одержання антитіл | |
EP0484787A3 (en) | Hcv-specific peptides, process for obtaining them and their use | |
BR8807310A (pt) | Polinucleotidio,polinucleotidio recombinante,vetor recombinante,celula hospedeira,sistema de expressao recombinante,celula transformada,polipeptidio,hcv,preparacao de polipeptidio,polipeptidio de hcv,polipeptidio purificado,polipeptidio recombinante,polipeptidio de fusao,anticorpo monoclonal,preparacao purificada de anticorpos policlonais,particula,sonda de polinucleotidio,kit anticorpo para epetopo de hcv,metodo para producao de polipeptidio,metodo para deteccao de acidos nucleicos de hcv,imunoensaio para detectar antigeno de hcv,imunoensaio para detectar anticorpos dirigidos contra antigeno de hcv,vacina para tratamento de infeccao de hcv,celula,celula infectada com hcv,metodo para producao de anticorpos para hcv e metodo para isolar cdna derivado do genoma de um agente infeccioso nao identificado | |
DK61595A (da) | Rekombinant DNA-molekyler, værtscelletransformering dermed, værtsceller indeholdende disse samt fremgangsmåde til fremstilling af et polypeptid af IFN-alfa-typen | |
FR2480779B2 (fr) | Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur | |
HU9303703D0 (en) | Hepatitis c virus (hcv) polypeptides | |
PT102022A (pt) | Processo para a producao e purificacao de astaloglicoprotetinas adequadas para uso em vacinas e conjunto de materiais de ensaio para detectar a sua presenca | |
EP0151079A3 (en) | Vaccine against epstein-barr virus | |
IE863325L (en) | Producing polypeptides in virally infected insect cells | |
DK35891A (da) | Praktisk taget rent, antigenisk peptid eller protein med en epitop af haemophilus influenzae, dets fremstilling og anvendelse | |
PT733643E (pt) | Polipeptido proteico membranar possuindo funcao de suporte do crescimento de pre-celulas b e gene para este | |
DK326289A (da) | Fremgangsmaade til fremstilling af et protein ud fra gaersvampe under anvendelse af et inducerbart system, samt vektorer og transformerede stammer til brug ved fremgangsmaaden | |
SE8601940D0 (sv) | Preparation of fused proteins, antibodies and processes therefor | |
EP0503950A3 (en) | Method of purifying recombinant hepatitis b virus surface proteins from recombinant cells | |
Mosser et al. | Proteins of Rous-associated virus type 61: polypeptide stoichiometry and evidence that glycoprotein gp35 is not a cleavage product of gp85 | |
CA2084521A1 (en) | Hepatitis c virus antigen polypeptide, production method therefor, and antibody detection method | |
RU94045154A (ru) | Полипептиды, их фрагменты и варианты, препарат, днк вектор, клетка, способ продукции полипептида, вакцины, способы защиты, антитело и его фрагмент, их применение, применение днк, способ идентификации антигена | |
EP0754755A3 (de) | Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern | |
WO1988009809A3 (en) | Cell system for expression of recombinant protein without production of virus | |
PT89041A (pt) | Metodo de preparacao de diagnosticos e vacinas nanbv | |
EP0571337A3 (en) | Process to purify proteins from cell systems | |
KR970061917A (ko) | 헤르페스 심플렉스 바이러스 당단백질의 항원 결정부위와 b형 간염 바이러스의 표면 항원 단백질의 융합단백질 | |
PT96223A (pt) | Processo para a preparacao de um agente viral responsavel pela hepatite nao-a bnao-b de pos-transfusao |